Recent large-scale sequencing studies report recurrent somatic mutations in the blood of elderly individuals in genes previously linked to clonal expansion of hematopoietic stem cells [1] [2] [3] [4] . Particularly for DNMT3A and TET2, a steep ageassociated increase in the prevalence of somatic mutations is observed from middle age onward [2] [3] [4] . In addition, prospective analyses performed in predominantly middle-aged individuals show an increased risk for all-cause mortality for carriers of such mutations as compared with non-carriers [3, 4] . Jointly, these data suggest a rapidly increasing vulnerability among the elderly for adverse health effects associated with clonal expansion of hematopoietic stem cells.
Aim & Approach
We investigated the association between all-cause mortality and carriership of somatic mutations in genes linked to clonal expansion of hematopoietic stem cells in a large elderly subsample (N = 864; age ≥ 80 years) derived from 2 large-scale community-dwelling Dutch cohort studies [5, 6] .
Uncompromised ten-year survival of elderly carriers 
Materials and Methods
We investigated whole-blood derived genomes of 646 individuals of 80 years and older from the Rotterdam Study [5] (RS; mean age at inclusion, 84.6 years; range, 80.0-105.8 years) and 218 individuals of 89 years and older from the Leiden Longevity Study [6] (LLS; mean age at inclusion, 94.0 years; range, 88.9-103.4 years). Selected elderly participants of the RS and LLS were followed for all-cause mortality for a median 8.7 and 9.2 years, respectively, which was sufficiently long to identify the age at death of 81.3% and 93.6% of the respective study subsamples.
Mutational Analysis
We analyzed DNA sequencing data for rare truncation variants and known hotspot variants in 15 genes previously reported by large-scale sequencing studies to harbor somatic mutations in the blood of normal individuals [2-4]. 
